Intermediate Reports

In accordance with the Israeli Companies Law, 5759-1999 (the “Companies Law”) and the Companies Regulations (Notice and Advertisement of a General Meeting...

Download

May 8, 2022

Novolog to Report 2022 First Quarter Results and Host Conference Call on 18.5.22

Novolog (Pharm-Up 1966) Ltd. is announce that its financial statements for 2022 will be published on Wednesday , May 18, 2022...

Download

March 14, 2022

In March 14th 2022, the company announced distribution of dividend in the amount of NIS 15.4 million

Download

March 9, 2022

May 8, 2022

Novolog to Report 2021 Full Year and Fourth Quarter Results and Host Conference Call on 14.3.22

Novolog (Pharm-Up 1966) Ltd. is announce that its financial statements for 2021 will be published on Monday, March 14, 2022...

Download

January 3, 2022

March 10, 2022

Novolog reports that it has signed an agreement to acquire 55% of the shares of Ein-Tal

Download

March 17, 2021

March 10, 2022

In March 2021, the Company's Board of Directors approved a dividend payment to the company’s shareholders at the sum of ILS 16 million, as a supplement to the dividend in the total amount of ILS 28 million for the year 2020

Download

March 4, 2021

March 10, 2022

Novolog acquired 75% of the shares of American Medical Laboratories (AML) for about ILS 21 million

Download

December 30, 2020

March 10, 2022

Private Placement has been placed through the allocation of 40.95 million new shares in the Company at a price of NIS 2.93 per share, raising proceeds of NIS 120 million

Intermediate Reports

Aviad Busi joins Novolog as CEO of Novolog Group

Company’s Annual General Meeting of Shareholders will be held in May 24, 2023

Eran Taus the CEO of the company, has decided to resign from his position on October 17th, 2023.

Began to have an interest - Clal Insurance Business Holdings Ltd

Eli Dahan is no longer an interested party

In March 20th 2023, the company announced distribution of dividend in the amount of NIS 16.9 million

The publication date for the financial statements of 2022 is March 20th, 2023, with a conference call scheduled for the same date at 11:00 AM

Appointment of director - Varda Shalev, as of 11.12.22

Cessation of Director Doron Steiger as of 11/30/22

Appointment of director - Tamar Gottlieb, as of November 20, 2022

In November 16th 2022, the company announced distribution of dividend in the amount of NIS 16.5 million Copy

Cessation of Director Jonathan Kaplan as of 11/13/22

Novolog acquires 75% of Pronto Diagnostics for about ILS 11 million

Novolog acquires 60% of Gsap Biomed for about ILS 33 million

Company’s Annual General Meeting of Shareholders will be held on Thursday, June 23, 2022

Novolog to Report 2022 First Quarter Results and Host Conference Call on 18.5.22

In March 14th 2022, the company announced distribution of dividend in the amount of NIS 15.4 million

Novolog to Report 2021 Full Year and Fourth Quarter Results and Host Conference Call on 14.3.22

Novolog reports that it has signed an agreement to acquire 55% of the shares of Ein-Tal

In March 2021, the Company's Board of Directors approved a dividend payment to the company’s shareholders at the sum of ILS 16 million, as a supplement to the dividend in the total amount of ILS 28 million for the year 2020

Novolog acquired 75% of the shares of American Medical Laboratories (AML) for about ILS 21 million

Private Placement has been placed through the allocation of 40.95 million new shares in the Company at a price of NIS 2.93 per share, raising proceeds of NIS 120 million

Novolog acquires 51% of Salus Ltd.’s shares for about ILS 9.2 million

STAY INFORMED

About Us

Businesses

Careers

Investors

Newsroom

Contact Us